Rhythm Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
RYTM Key Statistics
Stock Snapshot
With a market cap of 7.78B, Rhythm Pharmaceuticals(RYTM) trades at $113.34. The stock has a price-to-earnings ratio of -34.74.
On 2026-01-14, Rhythm Pharmaceuticals(RYTM) stock traded between a low of $106.08 and a high of $113.53. Shares are currently priced at $113.34, which is +6.8% above the low and -0.2% below the high.
Rhythm Pharmaceuticals(RYTM) shares are trading with a volume of 491.51K, against a daily average of 626.98K.
In the last year, Rhythm Pharmaceuticals(RYTM) shares hit a 52-week high of $122.20 and a 52-week low of $45.91.
In the last year, Rhythm Pharmaceuticals(RYTM) shares hit a 52-week high of $122.20 and a 52-week low of $45.91.
RYTM News
Rhythm Pharmaceuticals (RYTM) is back in focus after issuing preliminary 2025 guidance, highlighting IMCIVREE revenue estimates and upcoming trial milestones th...
Claim 70% Off TipRanks Premium Rhythm Pharmaceuticals ( (RYTM) ) has shared an announcement. On January 9, 2026, Rhythm Pharmaceuticals reported preliminary,...